A Nanaimo lab site expansion project will strengthen the facility’s magic mushroom research, say company executives.
Articles
Cannabis may have some beneficial effects on symptoms of obsessive-compulsive disorder
An analysis of a large dataset of medical cannabis users has indicates that many people with obsessive-compulsive disorder report that their symptoms are reduced after smoking the substance.
The COVID Conundrum For Psychedelic Stocks
The COVID pandemic is making the need for psychedelic drugs and the commercial potential of the industry much greater. But there is a catch.
Connecticut Lawmakers Approve Marijuana Legalization Bill As Governor Pushes Competing Reform
A Connecticut House committee on Thursday approved a bill to legalize marijuana, a notable development as lawmakers work to reconcile what they’re proposing with the governor’s reform plan.
Traumatic Brain Injury (TBI): Six Psychedelics Companies Target $120 Billion Market
One huge market. Six horses in the race (so far). Lots of prize money to go around.
Catalent Signs Drug Development Agreement with Cybin Inc for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003)
Cybin inks a drug development agreement with Catalent, "the leading global provider" of drug delivery, development and manufacturing solutions.
Delaware Lawmakers Approve Marijuana Legalization Bill In Committee Vote
A much-anticipated bill to legalize marijuana in Delaware cleared its first committee hurdle on Wednesday after wide-ranging testimony about how and whether the state should enact the reform.
Study Shows Cannabinoids May Help With Pathological Tremors
A new study from the Department of Neuroscience at the Faculty of Health and Medical Sciences at the University of Copenhagen, published in Nature Neuroscience and titled “Spinal astroglial cannabinoid receptors control pathological tremor,” shows how cannabis could help those who suffer from pathological tremors.
COMPASS Pathways granted two US patents
Compass is granted two psilocybin formulation patents, for treatment-resistant depression and major depressive disorder.
New York Lawmakers Overcome Marijuana Legalization ‘Impasse’ And Expect Bill In ‘Next Day Or So’
A top New York senator said that lawmakers and the governor have successfully resolved an outstanding issue in marijuana legalization negotiations related to impaired driving, setting the stage for a formal introduction of new bill text within days.
Investing in Psychedelics with MindMed Stock
It was the late Robin Williams who once said, “Reality is just a crutch for people who can’t handle drugs.”
Psychedelic Drugs: The Miracle Drugs of the 21st Century
Are psychedelics "miracle drugs"? If we compare them to the first Miracle Drug, the answer seems to be "yes".
MindMed Announces Inclusion in FTSE Russell Indexes
MindMed has been added to the FTSE Global Micro-Cap Index and the FTSE Total-Cap Index.
University Gets Federal Grant to Study Processed Hemp as Cattle Feed
Oregon State University has received a $299,950 federal U.S. Department of Agriculture grant to study feeding spent hemp biomass to cattle.
Andrew Yang Urges Legalization Of Psilocybin And Marijuana At New York City Mayoral Forum
Andrew Yang, a former 2020 Democratic presidential candidate who is now running for mayor of New York City, said in a recent campaign forum that he supports legalizing psilocybin and marijuana.